WASHINGTON, April 21, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2022. For the quarter ended April 1, 2022, net earnings were $1.7 billion, or $2.31 per diluted common share which represents a 1.0% increase over the comparable 2021 period. Non-GAAP adjusted diluted net earnings per common... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2022 financial results before market opening on Wednesday, May 4, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go... Read more
Leading developer of assays for T cell measurement introduces Certimmune global immunology services to support vaccine manufacturers in their phased clinical trials WHAT: Oxford Immunotec, a PerkinElmer company, will exhibit at the World Vaccine Congress in Washington D.C. from April 18-21. This live, in-person event is the largest, most established meeting covering the entire vaccine... Read more
Shimadzu Group Sets New CO2 Emission Reduction TargetsMoving toward net zero CO2 emissions from overall business activities by 2050 Read more
Marlborough, MA – April 14, 2022 – Market leading innovator in laboratory digital transformation, Scitara, has announced a collaboration with scientific analytical technology leader, PerkinElmer. The move will support the integration of the PerkinElmer® Signals Research Suite™ informatics platform, which provides seamless, end-to-end scientific data and workflow management, with laboratory instruments, applications and resources via the... Read more
Two Shimadzu Pretreatment Systems for Analytical Instruments Receive Red Dot Awards—Red Dot Design Award 2022— Read more
Danaher Announces Conversion Date For Series A Mandatory Convertible Preferred Stock WASHINGTON, April 12, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its 4.75% Series A Mandatory Convertible Preferred Stock (the “Preferred Stock”), will automatically convert into shares of the Company’s Common Stock on April 15, 2022 (the “Conversion Date”). The conversion rate... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 12, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will release its first quarter 2022 financial results after market close on Tuesday, May 3, 2022. The Company will host a conference call the same day at 5:00 p.m. ET to... Read more